Efficacy and safety of acarbose in patients with type 2 diabetes mellitus insufficienly controlled with diet and sulfonylureas alone

Journal of the College of Physicians and Surgeons Pakistan

Volumn 10, Issue 12, 2000, Pages 473-476

  Mughal, M A ^a   Mahar, S A ^a   Memon, M Y ^a   Maheri, W M ^a   Tanwani, R K ^a  

^a ZIAUDDIN MEDICAL UNIVERSITY   (Pakistan)

Author keywords

Adverse effects; Blood glucose; Blood pressure; Body mass index; Body weight; Diabetes mellitus; Sulfonylurea compounds; Type 2

Indexed keywords

ACARBOSE; GLUCOSE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIET THERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE;

EID: 0034515295     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Type II diabetes mellitus
2. Pharmacologic therapy for type 2 diabetes mellitus
3. Oral pharmacologic management of type 2 diabetes
4. The use of insulin alone and in combination with oral agents in type 2 diabetes
5. A review of the safety and efficacy of acarbose in diabetes mellitus
6. Acarbose: An alphaglucosidase inhibitor
7. The efficacy of acarbose in the treatment of patients with non-insulin dependent diabetes mellitus. A multi centre controlled clinical trial
8. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance
9. The use of acarbose in type 2 diabetic patients in secondary failure: Effects on glycemic control and diet induced thermogenesis
10. Effects of the alpha-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: Pathophysiological and therapeutic implications
11. Glucose toxicity
12. Effect of long-term acarbose (Bay g 542I) therapy on metabolic control on non insulin dependent (type II) diabetes mellitus
13. Effect of acarbose on carbohydrate metabolism, electrolytes, minerals and vitamins in fairly well controlled non-insulin-dependent diabetes mellitus
14. Effectiveness of acarbose, an alpha glucosidase inhibitor, in uncontrolled non-obese non-insulin-dependent diabetes
15. The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus
16. Effect of acarbose on carbohydrate and lipid metabolism-in NIDDM patients poorly controlled by sulfonylureas
17. Approaches to the management of post-prandial hyperglycemia
18. Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo controlled study
19. Management of antidiabetic medication in overdose
20. Nutritional recommendations for diabetic patients and treatment with alpha glucosidase inhibitors
21. Safety profile of acarbose, an alpha glucosidase inhibitor